大洋洲 · 综合新闻 · PerthNow
Cancer vaccine cuts melanoma death risk by 42 per cent
Merck and Moderna have released results of a late-stage trial that showed an experimental mRNA vaccine slashed the risk that melanoma returns by 42 per cent.
在 PerthNow 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.perthnow.com.au)
